Journal Club: Slaying the Sleeper Cells of Aging with CAR T
The a16z Show9 Elo 2020

Journal Club: Slaying the Sleeper Cells of Aging with CAR T

CAR T therapy is a groundbreaking medicine that uses engineered T cells to attack cancer. But CAR T cells (that is, chimeric antigen receptor T cells) can be programmed to recognize a huge range of target proteins and cell types. So what other types of cells should we train CAR Ts to recognize and destroy to improve human health?

On this episode of the a16z Journal Club, a16z General Partner Jorge Conde, bio deal team partner Andy Tran, and Lauren Richardson discuss new research published in Nature in which the authors engineer CAR T cells to recognize and kill senescent cells. Cellular senescence is a process where cells stop dividing (sort of go to sleep), and in many cases this can be protective, like its role in tumor suppression, but if too many cells become senescent of if they are not removed, they can trigger inflammation and cause disease, like in atherosclerosis and type 2 diabetes. Critically, senescent cells build up as we age and contribute to a whole host of age-related conditions. In this episode we cover how the authors created these senescence killing (aka senolytic) CAR T cells, the diseases that could be treated with senolytic CAR Ts, the hurdles to getting them into the clinic, and how they could potentially be used to treat aging and possibly improve longevity.

Senolytic CAR T cells reverse senescence-associated pathologies in Nature (June 2020) by Corina Amor, Judith Feucht, Josef Leibold, Yu-Jui Ho, Changyu Zhu, Direna Alonso-Curbelo, Jorge Mansilla-Soto, Jacob A. Boyer, Xiang Li, Theodoros Giavridis, Amanda Kulick, Shauna Houlihan, Ellinor Peerschke, Scott L. Friedman, Vladimir Ponomarev, Alessandra Piersigilli, Michel Sadelain & Scott W. Lowe

a16z bio Journal Club (part of the a16z Podcast), curates and covers recent advances from the scientific literature -- what papers we’re reading, and why they matter from our perspective at the intersection of biology & technology. You can find all these episodes at a16z.com/journalclub.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaksot(1000)

Real Estate in a Pandemic: Homeowners and Buyers (Part 1)

Real Estate in a Pandemic: Homeowners and Buyers (Part 1)

This episode is the first in a two-part series that examines the pandemic’s impact on real estate. Part 1 focuses on prospective home buyers, sellers, and existing homeowners. Part 2 (streaming on 6/1...

16 Kesä 202024min

World’s Largest Supercomputer v. Biology’s Toughest Problems

World’s Largest Supercomputer v. Biology’s Toughest Problems

Proteins are molecular machines that must first assemble themselves to function. But how does a protein, which is produced as a linear string of amino acids, assume the complex three-dimensional struc...

14 Kesä 202032min

The Return of Home-based Healthcare

The Return of Home-based Healthcare

The way we deliver healthcare has changed enormously over the last century, shifting from house calls by doctors to your own to institutionalized settings like hospitals and clinics. But now that tren...

12 Kesä 202026min

The Future of Primary Care

The Future of Primary Care

Primary care was meant to be the front door to the healthcare system, but in some ways never set up for success to begin with. We need a new operating system for primary care—one with a different, dee...

11 Kesä 202030min

All about Section 230: What It Does and Doesn't Say

All about Section 230: What It Does and Doesn't Say

We cover the tricky but important topic of Section 230 of the Communications Decency Act. The 1996 law has been in the headlines a lot recently, in the context of Twitter, the president’s tweets, and ...

9 Kesä 202040min

What We Can't Reveal We Can't Heal

What We Can't Reveal We Can't Heal

Given recent events around George Floyd and far beyond, this special episode of the a16z Podcast features Shaka Senghor, a leading advocate for criminal justice reform (and bestselling author), and Te...

4 Kesä 20201h 1min

SaaS Go-to-Upmarket

SaaS Go-to-Upmarket

For a SaaS company, it's easier to move upmarket than down, and this gives SaaS startups the advantage against incumbents. In this episode,  David Ulevitch and our newest enterprise general partner Kr...

29 Touko 202021min

New Fan Engagement Models for Athletes and Influencers

New Fan Engagement Models for Athletes and Influencers

Today’s episode is about a practical application of crypto — namely, the way it can “tokenize” fandom. More broadly, it’s about fan engagement, and the increasingly blurred lines between sports, cultu...

26 Touko 202019min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
rss-rahapodi
mimmit-sijoittaa
rss-oivalluksia-rahasta-elamasta
hyva-paha-johtaminen
ostan-asuntoja-podcast
rss-rahamania
rahapuhetta
rss-sisalto-kuntoon
rss-paasipodi
rss-yritys-ja-erehdys
inderespodi
rss-sami-miettinen-neuvottelija
lakicast
rss-lahtijat
rss-startup-ministerio
rss-kaikki-somesta
rss-karon-grilli
rss-lentopaivakirjat